• Whitehawk Therapeutics will present a Trials-in-Progress poster on its Phase 1 study of HWK-007 at the ASCO Annual Meeting on May 30, 2026, from 1:30 p.m. to 4:30 p.m. CDT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA65551) on May 21, 2026, and is solely responsible for the information contained therein.